DIAMOND LEONARD: Open Payments
NPI 1740823087 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 43 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $421 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 24 | $1,004 |
| Neurocrine BioSciences, Inc. | 14 | $422 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Alpha Cognition USA, Inc. | 2 | $110 |
| ACADIA Pharmaceuticals Inc | 2 | $55 |
Products named: AUSTEDO XR, INGREZZA, COBENFY, Zunveyl, NUPLAZID.
Industry payments across FL — which companies pay providers there.
